Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Abattis Bioceuticals Corp (ATT.CN)

Abattis Bioceuticals Corp (ATT.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Abattis Bioceuticals Corp 1200 - 625 Howe Street Vancouver BC V6C 2M6 CAN

www.abattis.com P: 604-229-7911 F: 604-608-5688

Description:

Abattis Bioceuticals Corp is a Canadian life science and biotechnology company focuses on aggregating, integrating and investing in agricultural technologies and biotechnology services for the legal cannabis industry. It is primarily engaged in producing, licensing and marketing proprietary ingredients and formulas for use in the biopharma, nutraceutical, cosmetic and animal nutrition markets. The company is also engaged in growing, extraction, testing, propagation and online distribution.

Key Statistics

Overview:

Market Capitalization, $K 32,516
Shares Outstanding, K 477,804
Annual Sales, $ 357 K
Annual Net Income, $ -3,042 K
Last Quarter Sales, $ 226 K
Last Quarter Net Income, $ -907 K
60-Month Beta 0.36
% of Institutional Shareholders 0.10%

Growth:

1-Year Return -82.02%
3-Year Return 45.45%
5-Year Return 0.00%
5-Year Revenue Growth 115.27%

Per-Share Information:

Latest Earnings Date N/A
Earnings Per Share ttm -0.01
Dividend Payout Ratio 0.00%
Most Recent Split 1-5 on 09/11/12

ATT.CN Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -26.96%
Return-on-Assets % -19.84%
Profit Margin % -852.40%
Debt/Equity 0.01
Price/Sales N/A
Price/Book 0.47
Book Value/Share N/A
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar